에스바이오메딕스

304360 코스닥
34,000 800 (+2.41%)
기준 : 05/17
  • 시가총액
    3,885억
  • 주식수
    1,134만
  • PER
    -52.81배
  • PBR
    71.97배
  • ROE
    -136.30%
  • 결산월
    12월

24.1Q 업데이트 - 주요계정

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09
매출액(수익) 126126.9 131131.0 125125.4 137137.9 128128.2
내수 N/AN/A 1212.9 1212.9 99.4 33.6
수출 N/AN/A 8080.1 8080.1 6161.7 2626.5
기타 N/AN/A 131131.0 125125.4 137137.9 128128.2
매출원가 6262.6 6565.5 6363.7 6666.7 6464.5
원재료 N/AN/A 3131.9 3939.2 3838.2 3333.5
재고자산의변동 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타원가 N/AN/A -10-10.2 -16-16.3 -11-11.3 -13-13.5
인건비 N/AN/A 4242.2 3838.7 3838.2 3636.5
감가상각비 N/AN/A 1111.0 1010.9 1111.1 1111.5
기타 N/AN/A -9-9.5 -8-8.8 -9-9.5 -3-3.5
매출총이익 6464.3 6565.5 6161.7 7171.1 6363.7
판매비와관리비 124124.8 125125.4 122122.1 116116.1 107107.6
급여 N/AN/A 1919.1 1818.7 1717.9 1717.5
퇴직급여 N/AN/A 22.1 11.8 11.8 11.8
복리후생비 N/AN/A 33.3 22.9 22.6 22.3
임차료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수도광열비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
전산처리비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지급수수료 N/AN/A 1212.6 1010.8 99.2 88.5
용역비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 6565.0 6666.1 6565.2 6060.3
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A 11.7 11.3 00.0 -1-1.0
감가상각비 N/AN/A 44.4 44.0 33.1 33.1
무형자산상각비 N/AN/A 00.0 00.0 00.0 00.0
기타 N/AN/A 1616.9 1616.2 1515.9 1414.8
영업이익 -60-60.5 -59-59.8 -60-60.4 -44-44.9 -43-43.9
EBITDA N/AN/A -41-41.6 -45-45.8 -34-34.2 -38-38.2
금융손익 N/AN/A -3-3.0 -6-6.6 -9-9.7 -15-15.4
금융수익 66.6 66.4 44.2 33.1 33.6
이자수익 N/AN/A 22.6 11.4 11.4 11.4
외환거래이익 N/AN/A 0-0.8 11.0 11.0 11.0
외환차익 N/AN/A 0-0.5 0-0.7 0-0.7 0-0.7
외화환산이익 N/AN/A 0-0.2 0-0.2 0-0.2 0-0.2
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A 0-0.8 0-0.1 0-0.1 0-0.1
금융자산평가이익 N/AN/A 0-0.1 00.0 00.0 00.0
파생상품이익 N/AN/A 22.0 N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.0 11.5 0-0.4 0-0.9
금융비용 88.8 99.5 1010.9 1212.9 1919.0
이자비용 N/AN/A 88.8 77.2 77.2 77.2
외환거래손실 N/AN/A 0-0.4 0-0.8 0-0.8 0-0.8
외환차손 N/AN/A 0-0.3 0-0.5 0-0.5 0-0.5
외화환산손실 N/AN/A 0-0.1 0-0.2 0-0.2 0-0.2
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A 0-0.2 99.6 99.6 99.6
기타 N/AN/A 00.0 -6-6.8 -4-4.8 11.2
기타영업외손익 00.0 0-0.4 0-0.4 0-0.2 0-0.2
기타영업외수익 11.0 0-0.7 0-0.4 0-0.4 0-0.4
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A 00.0 N/AN/A N/AN/A N/AN/A
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A 0-0.2 N/AN/A N/AN/A N/AN/A
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 0-0.5 0-0.4 0-0.4 0-0.4
기타영업외비용 11.0 11.1 00.0 0-0.2 0-0.2
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A 00.0 00.0 00.0 00.0
기부금 N/AN/A 00.0 N/AN/A N/AN/A N/AN/A
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 0-0.1 N/AN/A N/AN/A N/AN/A
무형자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 11.0 00.0 0-0.1 0-0.1
종속기업및관계기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 -62-62.6 -63-63.3 -66-66.6 -54-54.4 -59-59.0
법인세비용 0-0.5 11.2 -1-1.8 -1-1.8 -3-3.8
중단사업이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
당기순이익 -63-63.2 -64-64.6 -64-64.8 -52-52.6 -55-55.2
지배지분 순이익 -73-73.5 -75-75.2 -73-73.0 -68-68.0 -69-69.8
비지배지분 순이익 1010.3 1010.6 88.2 1515.4 1414.6
기타포괄이익 -2-2.3 -2-2.3 0-0.8 0-0.8 0-0.8
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
해외사업환산손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A -2-2.3 0-0.8 0-0.8 0-0.8
총포괄이익 -65-65.5 -66-66.9 -63-63.9 -51-51.7 -54-54.3
지배지분 총포괄이익 -75-75.4 -77-77.1 -72-72.5 -67-67.5 -69-69.3
비지배지분 총포괄이익 99.9 1010.2 88.6 1515.8 1515.0
주당순이익 N/AN/A -690-690.0 -686-686.9 -657-657.2 -683-683.6
시가총액 N/AN/A 1,3031,303.7 1,2471,247.0 1,1571,157.1 N/AN/A
주가 N/AN/A 11,50011,500.0 11,00011,000.0 10,29010,290.0 N/AN/A
주가수익배수 N/AN/A -17.33-17.33 -17.07-17.07 -16.99-16.99 N/AN/A

20년 재무제표를 한번에! 실적시즌 혜택! 지금 회원가입하면 종목 재무분석 매일 3건 무료! 회원가입

실적시즌! 종목 재무분석 매일 3건 무료! 회원가입